[{"id":"bb77e407-4e9a-4fb6-b731-4f05dd35e66d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00559182","created_at":"2021-01-18T02:02:15.651Z","updated_at":"2024-07-02T16:36:06.652Z","phase":"Phase 1","brief_title":"A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)","source_id_and_acronym":"NCT00559182","lead_sponsor":"Merck Sharp \u0026 Dohme LLC","biomarkers":" MET","pipe":"","alterations":" ","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HQP8361 • lovastatin • omeprazole"],"overall_status":"Completed","enrollment":" Enrollment 47","initiation":"Initiation: 12/05/2007","start_date":" 12/05/2007","primary_txt":" Primary completion: 06/10/2010","primary_completion_date":" 06/10/2010","study_txt":" Completion: 07/09/2010","study_completion_date":" 07/09/2010","last_update_posted":"2022-07-26"},{"id":"a87e3c49-c60d-4e33-a7c5-006bbd064b96","acronym":"","url":"https://clinicaltrials.gov/study/NCT03826940","created_at":"2021-01-18T18:54:02.685Z","updated_at":"2024-07-02T16:36:32.463Z","phase":"","brief_title":"From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1","source_id_and_acronym":"NCT03826940","lead_sponsor":"University of Coimbra","biomarkers":" NF1","pipe":"","alterations":" ","tags":["NF1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lovastatin"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 02/19/2019","start_date":" 02/19/2019","primary_txt":" Primary completion: 03/31/2020","primary_completion_date":" 03/31/2020","study_txt":" Completion: 08/31/2020","study_completion_date":" 08/31/2020","last_update_posted":"2021-04-02"},{"id":"8ddcb73c-ed52-4928-a079-5582d183abbd","acronym":"STARS","url":"https://clinicaltrials.gov/study/NCT00853580","created_at":"2021-01-18T03:15:03.208Z","updated_at":"2024-07-02T16:37:13.118Z","phase":"Phase 2","brief_title":"A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1","source_id_and_acronym":"NCT00853580 - STARS","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" NF1","pipe":"","alterations":" ","tags":["NF1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lovastatin"],"overall_status":"Completed","enrollment":" Enrollment 146","initiation":"Initiation: 07/01/2009","start_date":" 07/01/2009","primary_txt":" Primary completion: 05/01/2014","primary_completion_date":" 05/01/2014","study_txt":" Completion: 12/01/2016","study_completion_date":" 12/01/2016","last_update_posted":"2018-03-12"},{"id":"0558f5bd-f04b-4ccf-9f2c-4cf3f27d360f","acronym":"","url":"https://clinicaltrials.gov/study/NCT00352599","created_at":"2021-01-18T01:13:14.121Z","updated_at":"2024-07-02T16:37:27.506Z","phase":"Phase 1","brief_title":"Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)","source_id_and_acronym":"NCT00352599","lead_sponsor":"University of California, Los Angeles","biomarkers":" NF1","pipe":"","alterations":" ","tags":["NF1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lovastatin"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 09/01/2009","start_date":" 09/01/2009","primary_txt":" Primary completion: 03/01/2014","primary_completion_date":" 03/01/2014","study_txt":" Completion: 03/01/2014","study_completion_date":" 03/01/2014","last_update_posted":"2016-11-22"}]